AstraZeneca's coronavirus vaxine not recommended for seniors in Canada

Lawrence Kim
Марта 3, 2021

While Health Canada approved of the Oxford University-AstraZeneca COVID-19 vaccine, Nova Scotia's top doctor said the province will only see a small number of doses.

But similar advice initially issued in Europe began to be revisited Monday, with France overturning its earlier decision against using it on seniors, and Germany in the midst of reconsidering it.

The J&J vaccine is authorized for people ages 18 and older. It is cheaper and easier to handle than the Pfizer-BioNTech vaccine, which needs deep-cold storage that is not widespread in many developing nations.

As for herself, Brum said she has allergies that she believes may put her at greater risk of adverse reactions and so she is unsure whether she can take any vaccine.

The panel's advice helps provincial governments determine how best to use the vaccines available to them but provinces can make their own calls about what to do.

'The advertising is important, so people understand how the vaccination program is operating, how they can find out when it will be their turn and answer any questions they have about the vaccines, ' Health Minister Greg Hunt said.

"As soon as we have those doses, we want to roll them out as quickly as possible".

More Americans are willing to get a covid-19 vaccine, new polling suggests.

"It's a bit like the AstraZeneca vaccine - uses an adenovirus to deliver the genetic material for the spike protein".

It appears unlikely that British Columbians will be able to select which COVID-19 vaccine they receive as mass vaccination clinics expand across the province in the coming months, but the arrival of the AstraZeneca vaccine may lead to other significant changes to the province's rollout.

He told a Downing Street news conference that Public Health England data, which found the vaccine is more than 80 percent effective at preventing hospital admission up to four weeks after the first dose, "clearly vindicated" Britain's approach.

Among the over 80s, there was an overall 81% reduction in the numbers admitted to hospital when the results for both vaccines were combined.

"We're starting to get real world evidence".

Initial reports showed the vaccine was up to 90% effectiveagainst COVID-19.

Pifzer-BioNTech and Moderna both had more substantial data for older participants in the clinical trials.

"On 3 February 2021, The Lancet journal said, 'COVID-19 Vaccine AstraZeneca confirms 100 per cent protection against severe disease, hospitalisation and death in the primary analysis of phase three trials'".

Dr. Supriya Sharma, the chief medical adviser at Health Canada, also told the CBC on Sunday that the regulator had received additional information over the weekend from Johnson and Johnson, which is seeking approval for its own vaccine.

Britain has given the first dose of one of the two vaccines to more than 20 million people as part of a mass rollout that is seen as vital in taming one of the world's worst outbreaks, which has so far claimed nearly 123,000 lives.

He said that "in time", he expected the UK's vaccine rollout to lower levels of the virus, reduce the likelihood of infections affecting the older and more vulnerable and result in milder cases for people in those groups.

Other reports by

Discuss This Article